WHO : WHO has issued an alert against a cough syrup manufacturing company in India. WHO has issued a medical product alert on cough and cold syrup made by Maiden Pharmaceuticals of India. The WHO has issued an alert following kidney injuries and the death of 66 children in The Gambia. Reuters quoted the WHO as saying that further investigations are underway with the company and regulatory authorities.
Laboratory analysis of samples of each of the four products made by Maiden Pharmaceuticals of India confirmed that they contained unacceptable levels of diethylene glycol and ethylene glycol, according to WHO. A medical product alert states. Director General of WHO Dr. Tedros Adhanom Ghebreyesus said the WHO today issued a medical product alert for four contaminated medicines linked to serious kidney injuries and 66 deaths among children in The Gambia. The death of these children has come as a shock to their families.
"The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India. WHO is conducting further investigation with the company and regulatory authorities in India"-@DrTedros https://t.co/PceTWc836t
— World Health Organization (WHO) (@WHO) October 5, 2022
Alert to other countries
"Four medicines namely Cough and Cold Syrup are manufactured by Maiden Pharmaceuticals Limited in India. WHO is conducting further investigations with the relevant company and regulatory authorities in India. Contaminated products have so far only been found in The Gambia, they may have been distributed to other countries. WHO recommends the detection and destruction of these products to prevent further harm to patients in all countries, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said.
Get the more latest India news updates